NP Life Sciences Health Industry Group Inc. Income Statement
ACAT|5 years of annual SEC 10-K data (FY2019-FY2023)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 5 fiscal years. All figures from audited SEC 10-K filings.
NP Life Sciences Health Industry Group Inc. reported $164,621 in revenue and $2,935 in net loss for FY2023. Revenue has grown at a 39.9% compound annual rate over the past 4 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -1.61 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $164.6K | $102.0K | $35.0K | $15.0K | $43.0K |
| SG&A Expense | $165.3K | $120.9K | $100.7K | $146.1K | $151.9K |
| Operating Income | -$690 | -$18.9K | -$65.7K | -$131.1K | -$108.9K |
| Interest Expense | $645 | $1 | - | - | - |
| Income Tax | $1.6K | - | - | - | - |
| Net Income | -$2.9K | -$18.9K | -$65.7K | -$131.1K | -$108.8K |
| EPS (Basic) | $0.00 | $0.00 | - | - | - |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares Outstanding | 43.0M | 43.0M | 43.0M | 43.0M | 66.7K |
| Operating Margin | -0.4% | -18.5% | -187.7% | -873.9% | -253.2% |
| Profit Margin | -1.8% | -18.5% | -187.7% | -873.8% | -253.1% |